3 most recent filings and news items mentioning TNGX. Updated every 60 seconds.
curl "https://api.brieftape.com/v1/tickers/TNGX/news?limit=20"
Pull TNGX filings straight into your trading bot, model, or app.
Get an API key — free tier: 10,000 calls/dayTango Therapeutics appointed Robert Azelby to its Board of Directors. His oncology commercialization expertise is viewed as a strategic asset as the company advances its pipeline.
View filing at SEC.gov →Apple, SUNation Energy, Tango Therapeutics, Applied Digital And Cerebras Systems: Why These 5 Stocks Are On Investors' Radars Today
View filing at SEC.gov →Tango Therapeutics announced positive Phase 1/2 data showing a combination of its PRMT5 inhibitor vopimetostat and Revolution Medicines' RAS inhibitor daraxonrasib achieved 92% objective response rate in MTAP-deleted pancreatic cancer patients, with 90% maintaining progression-fr
View filing at SEC.gov →